Black Phosphorus Nanosheets-Loaded Single-Atom Gold Nanoenzymes for Enhanced Photodynamic Therapy of Hepatocellular Carcinoma.

IF 6.6 2区 医学 Q1 NANOSCIENCE & NANOTECHNOLOGY
International Journal of Nanomedicine Pub Date : 2024-11-26 eCollection Date: 2024-01-01 DOI:10.2147/IJN.S414938
Jianmeng Zhu, Hongqin Wang, Kaiqiang Li, Xiuze Yuan, Wenzhong Hong
{"title":"Black Phosphorus Nanosheets-Loaded Single-Atom Gold Nanoenzymes for Enhanced Photodynamic Therapy of Hepatocellular Carcinoma.","authors":"Jianmeng Zhu, Hongqin Wang, Kaiqiang Li, Xiuze Yuan, Wenzhong Hong","doi":"10.2147/IJN.S414938","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Conventional treatments for hepatocellular carcinoma (HCC) lack efficacy and targeting abilities. Photodynamic therapy (PDT) has emerged as a promising alternative for targeted and minimally invasive tumor treatments. However, many biomaterials used in PDT pose biosafety concerns and insufficient enzyme activity often leads to limited reactive oxygen species (ROS) production, resulting in poor PDT efficacy. Single-atom nanoenzymes have attracted much research attention as a novel type of high-performance nanoenzymes.</p><p><strong>Methods: </strong>In this study, we prepared black phosphorus nanosheets (BP) with good biocompatibility as a platform and loaded single-atom gold nanoenzymes onto BP nanosheets to treat HCC. To enhance the stability and targeting ability of the nanohybrid, it was PEGylated and modified with folate (FA) targeting molecules.</p><p><strong>Results: </strong>The designed BP/single-atom nanoenzyme platform can target tumor tissues and generate substantial amounts of reactive oxygen species (ROS), demonstrating biocompatibility and improved catalytic activity.</p><p><strong>Conclusion: </strong>The nanoplatform effectively targets HCC and enhances PDT efficacy by increasing ROS production, offering a promising approach for HCC treatment.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"19 ","pages":"12583-12592"},"PeriodicalIF":6.6000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S414938","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Conventional treatments for hepatocellular carcinoma (HCC) lack efficacy and targeting abilities. Photodynamic therapy (PDT) has emerged as a promising alternative for targeted and minimally invasive tumor treatments. However, many biomaterials used in PDT pose biosafety concerns and insufficient enzyme activity often leads to limited reactive oxygen species (ROS) production, resulting in poor PDT efficacy. Single-atom nanoenzymes have attracted much research attention as a novel type of high-performance nanoenzymes.

Methods: In this study, we prepared black phosphorus nanosheets (BP) with good biocompatibility as a platform and loaded single-atom gold nanoenzymes onto BP nanosheets to treat HCC. To enhance the stability and targeting ability of the nanohybrid, it was PEGylated and modified with folate (FA) targeting molecules.

Results: The designed BP/single-atom nanoenzyme platform can target tumor tissues and generate substantial amounts of reactive oxygen species (ROS), demonstrating biocompatibility and improved catalytic activity.

Conclusion: The nanoplatform effectively targets HCC and enhances PDT efficacy by increasing ROS production, offering a promising approach for HCC treatment.

求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Nanomedicine
International Journal of Nanomedicine NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
CiteScore
14.40
自引率
3.80%
发文量
511
审稿时长
1.4 months
期刊介绍: The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area. With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field. Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信